45 results on '"Barbaud A"'
Search Results
2. Discoid drug‐induced lupus erythematosus induced by antitumor necrosis factor agents is a very rare subtype of cutaneous lupus: Three cases and literature review
- Author
-
Olivier Fain, Noémie Abisror, François Chasset, Caroline Beal, Camille Francès, Alice Brehon, Sarah Guégan, Annick Barbaud, Emmanuel Alexis Laffitte, and Philippe Moguelet
- Subjects
medicine.medical_specialty ,Necrosis ,Lupus erythematosus ,Drug Induced Lupus ,business.industry ,Dermatology ,General Medicine ,medicine.disease ,Skin Diseases ,Lupus Erythematosus, Discoid ,Pharmaceutical Preparations ,Lupus Erythematosus, Cutaneous ,medicine ,Humans ,Lupus Erythematosus, Systemic ,medicine.symptom ,business ,Drug-induced lupus erythematosus ,Cutaneous lupus - Published
- 2020
3. Response to rituximab of pseudotumoral digital nodules in a patient with granulomatosis with polyangiitis with alpha‐1 antitrypsin deficiency: A case report
- Author
-
Aitmehdi, Raphaël, primary, Moguelet, Philippe, additional, Godot, Sophie, additional, Chazerain, Pascal, additional, Senet, Patricia, additional, Barbaud, Annick, additional, Frances, Camille, additional, and Chasset, François, additional
- Published
- 2020
- Full Text
- View/download PDF
4. Discoid drug‐induced lupus erythematosus induced by antitumor necrosis factor agents is a very rare subtype of cutaneous lupus: Three cases and literature review
- Author
-
Brehon, Alice, primary, Moguelet, Philippe, additional, Guégan, Sarah, additional, Abisror, Noémie, additional, Barbaud, Annick, additional, Beal, Caroline, additional, Laffitte, Emmanuel, additional, Fain, Olivier, additional, Francès, Camille, additional, and Chasset, François, additional
- Published
- 2020
- Full Text
- View/download PDF
5. Sequential Assessment of Cell Cycle S Phase in Flow Cytometry: A Non-Isotopic Method to Measure Lymphocyte Activation In Vitro
- Author
-
M. N. Kolopp‐Sarda, M. C. Béné, A. Barbaud, Ch. Kohler, A. De March‐Kennel, and G. Faure
- Subjects
Adult ,G2 Phase ,Lymphocyte ,Mitosis ,Lymphocyte proliferation ,Biology ,Lymphocyte Activation ,lcsh:RC254-282 ,S Phase ,Flow cytometry ,chemistry.chemical_compound ,phytohaemagglutinin ,Antigen ,Tetanus Toxoid ,medicine ,Humans ,Lymphocytes ,Phytohemagglutinins ,lcsh:QH573-671 ,Phytohaemagglutinin ,medicine.diagnostic_test ,lcsh:Cytology ,flow cytometry ,Cell cycle ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Molecular biology ,In vitro ,Kinetics ,medicine.anatomical_structure ,chemistry ,biology.protein ,cell cycle ,Other ,Mitogens ,Thymidine - Abstract
Lymphocyte multiplication can be inducedin vitroby mitogens or specific antigens, and is usually measured using isotopic methods involving tritiated thymidine. Cellular proliferation can also be analyzed by flow cytometry techniques based on cell cycle analysis through the measurement of DNA content. We applied this method to lymphocytes from 113 individuals, to evaluate lymphocyte proliferation after stimulationin vitroby a mitogen (phytohaemagglutinin, PHA) or a recall antigen (tetanus toxoid), using a kinetic approach with four points sequential measurements of the S and G2 phases over six days of culture. The proportion of cells in S phase after PHA stimulation was significantly higher than in controls overall and as early as on day three of the culture. Activation with a recall antigen significantly induced increasing S phase cell proportions up to day six. These data suggest that flow cytometric assessment of the S phase could be a useful alternative to isotopic methods measuring lymphocyte reactivityin vitro.
- Published
- 1997
6. Sequential assessment of cell cycle S phase in flow cytometry: a non-isotopic method to measure lymphocyte activation in vitro.
- Author
-
Kohler, Kolopp-Sarda, De March-Kennel, Barbaud, Béné, and Faure
- Subjects
CELL proliferation ,FLOW cytometry ,LYMPHOCYTES - Abstract
Lymphocyte multiplication can be induced in vitro by mitogens or specific antigens, and is usually measured using isotopic methods involving tritiated thymidine. Cellular proliferation can also be analyzed by flow cytometry techniques based on cell cycle analysis through the measurement of DNA content. We applied this method to lymphocytes from 113 individuals, to evaluate lymphocyte proliferation after stimulation in vitro by a mitogen (phytohaemagglutinin, PHA) or a recall antigen (tetanus toxoid), using a kinetic approach with four points sequential measurements of the S and G2 phases over six days of culture. The proportion of cells in S phase after PHA stimulation was significantly higher than in controls overall and as early as on day three of the culture. Activation with a recall antigen significantly induced increasing S phase cell proportions up to day six. These data suggest that flow cytometric assessment of the S phase could be a useful alternative to isotopic methods measuring lymphocyte reactivity in vitro. [ABSTRACT FROM AUTHOR]
- Published
- 1997
- Full Text
- View/download PDF
7. Sequential Assessment of Cell Cycle S Phase in Flow Cytometry: A Non-Isotopic Method to Measure Lymphocyte ActivationIn Vitro
- Author
-
Kohler, Ch., primary, Kolopp‐Sarda, M. N., additional, De March‐Kennel, A., additional, Barbaud, A., additional, Béné, M. C., additional, and Faure, G. C., additional
- Published
- 1997
- Full Text
- View/download PDF
8. Omeprazole Induced Rapid Drug Reaction with Eosinophilia, Systemic Symptoms, and Cross-Reactivity in Delayed-Type Hypersensitivity Associated with Proton-Pump Inhibitors: A Case Report and Literature Review.
- Author
-
Pinyopornpanish, Kanokkarn, Pinyopornpanish, Kanokporn, Pinyopornpanish, Kanokwan, Benjanuwattra, Juthipong, Teepapan, Putthapon, Chungcharoenpanich, Apinya, and Laisuan, Wannada
- Subjects
LITERATURE reviews ,DRESS syndrome ,OMEPRAZOLE ,EOSINOPHILIA ,SYMPTOMS ,PULMONARY eosinophilia - Abstract
Background. Omeprazole, a proton pump inhibitor (PPI), is a widely used and generally safe agent for treating acid-related gastrointestinal conditions. However, drug reaction with eosinophilia and systemic symptoms (DRESSs) syndrome has been reported. Objectives. To report a case of omeprazole-induced rapid DRESS syndrome and to review the literature. Methods. Descriptive analysis of one new case and a case series from literature review. Results. We report a case of 82-year-old woman presenting with rapid-onset of DRESS syndrome. The condition was initially suspected to be caused by antibiotic, but the definite diagnosis was eventually omeprazole-induced DRESS syndrome as suggested by the enzyme-linked immune absorbent spot (ELISpot) assay along with the clinical picture. Previous literatures regarding cases of PPI-induced DRESS syndrome were pooled for descriptive analysis. Among 21 PPI cases pooled, esomeprazole was the most commonly implicated PPI (52.4%), followed by pantoprazole (19.1%), and omeprazole along with lansoprazole (both 14.3%). The issue of cross-reactivities amongst PPIs remains uncertain. Nonetheless, in situations in which a PPIs are deemed necessary, a prudent approach could be considering a switch to an alternative agent with distinct chemical structure. Conclusion. PPI is commonly used safely as an agent for acid-related gastrointestinal conditions. However, PPI-induced rapid DRESS syndrome can occur, particularly with prior exposure history. ELISpot is an in vitro test, useful in identifying the culprit agent in patients with delayed-type hypersensitivity reaction. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. CMR 2005: 11.06: European multicenter study on contrast media hypersensitivity.
- Author
-
Brockow, K., Christiansen, C., Aberer, W., Barbaud, A., Bircher, A., Kanny, G., Pichler, W.J., Ring, J., Romano, A., and von Radnoth, I. Szantho
- Published
- 2006
- Full Text
- View/download PDF
10. Evaluation of Iodinated Contrast Media Use in Abdominal CT Scans in Cancer Assessments: A Cross-Sectional Study in Lomé (Togo).
- Author
-
Gbande, Pihou, N'timon, Bidamin, Tchakpedeou, Dermane Alassani, Tchaou, Mazamaesso, Adambounou, Kokou, Sonhaye, Lantam, Agoda-Koussema, Lama Kegdigoma, and Adjenou, Komlanvi
- Abstract
Background. There is great variability between centers regarding contrast injection protocols. They should only be injected if they can provide useful information for diagnosis with the necessary and sufficient quantity of iodine. We wanted to know through this study if the use of iodinated contrast media is optimised in abdominal CT scans performed for cancer assessment in Lomé. Materials and Methods. It was a cross-sectional, descriptive, and analytical study with a prospective collection over a period of 6 months in three CT units in Lomé. It involved abdominal CT scans performed for oncological evaluation. Data were reported as the mean ± standard deviation. The Pearson correlation coefficient, ANOVA, chi-square, and the Fisher test were used. Results. A total of 218 examinations were recorded. The female sex represented 56.88% of the patients. The mean age was 50.92 ± 15.78 years. The mean weight was 70.46 ± 15.23 kg. The mean BMI was 24.91 ± 5.32 kg/m
2 . The examinations were performed with a voltage of 120 kV in 195 cases (89.45%). The mean dose of injected iodine was 0.42 ± 0.09 gI/kg with a dose of 0.40 gI/kg at 80 kV and 0.45 gI/kg at 130 kV. The mean injection rate was 2.90 ± 0.34 mL/s. The mean injected volume was 83.19 ± 7.29 mL. The mean duration of the injection was 30.60 ± 7.39 s. The mean iodine delivery rate was 0.98 ± 0.17 gI/s. There was no saline injection in 152 cases (69.72%). Liver contrast enhancement was satisfactory in 94.5% of cases. There was a strong negative linear correlation between the dose of injected iodine and weight. Conclusions. Optimization guidelines for the use of iodinated contrast media are not always applied. Therefore, monitoring and benchmarking programmes for iodinated contrast injection protocols that involve all radiology personnel should be implemented. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
11. In Vitro Assays for Diagnosis of Drug-Induced Nonsevere Exanthemas: A Systematic Review and Meta-Analysis.
- Author
-
Drygala, Szymon, Rdzanek, Elzbieta, Porebski, Grzegorz, and Dubiela, Pawel
- Subjects
DRUG side effects ,DRUG allergy ,LYMPHOCYTE transformation ,DIAGNOSIS ,SENSITIVITY & specificity (Statistics) - Abstract
Frequent mislabelled causal relationship between drug hypersensitivity reactions and culprit drugs reinforces the need for an accurate diagnosis. The systematic reviews and meta-analyses of in vitro assays published so far focused on immediate reactions and the most severe delayed reactions, while the most frequent drug-induced delayed reactions—nonsevere exanthemas—have been underestimated. We aim to fill this gap. A systematic review of studies on in vitro assays used in the diagnosis of nonsevere drug-induced delayed reactions was conducted following the methodology of Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies Statement. The EMBASE and PubMed databases were searched. We have included 33 studies from which we extracted the data, then performed meta-analysis where possible, or synthesised the evidence narratively. The quality of the analysed studies was assessed with the QUADAS-2 tool. The tests identified the most frequently were lymphocyte transformation test (LTT), ELISpot, and ELISA. In the meta-analysis carried out for LTT in reactions induce by beta-lactams, the pool estimate of sensitivity and specificity amounted to 49.1% (95% CI: 14.0%, 85.0%) and 94.6% (95% CI: 81.7%, 98.6%), respectively. The studies showed heterogeneity in study design and laboratory settings, which resulted in a wide range of specificity and sensitivity of testing. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Clinical features, treatment outcomes and prognostic factors of allopurinol‐induced DRESS in 52 patients.
- Author
-
Liu, Qianling, Zhao, Sumei, and Chen, Wei
- Subjects
FEVER ,ADRENOCORTICAL hormones ,CHRONIC diseases ,ALLOPURINOL ,DRESS syndrome ,ALLELES ,TREATMENT effectiveness ,EOSINOPHILIA ,CASE studies ,DRUG allergy ,DRUG side effects ,SYMPTOMS - Abstract
What is Known and Objective: Allopurinol‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but serious and potentially life‐threatening drug hypersensitivity syndrome. In this study, we aimed to investigate the clinical features, treatment outcomes, and prognostic factors of allopurinol‐induced DRESS. Methods: Case reports of allopurinol‐induced DRESS published by China from January 2000 to August 2021 were retrieved from CNKI, Wan Fang, VIP, and PubMed databases for analysis. Results and Discussion: This study included 52 patients, consisting of 41 (78.8%) males and 11 (21.2%) females (M:F = 3.7:1). The mean of age was 56.1 ± 17.1 years (range: 18–86 years). The mean of latency periods was 24.6 ± 15.0 days (range:1‐63 days). Most patients presented with fever, cutaneous eruption, eosinophilia, lymphadenopathy, and facial edema. 36/52 (69.2%) patients showed two or more internal organs involved. Liver and kidney injuries were the most common visceral manifestation. Pulmonary involvement (34.6%), cardiac involvement (25.0%) and gastrointestinal involvement (21.2%) were relatively less known but severe complications. 2/52 (3.8%) patients showed nervous system involved, presenting as leukoencephalopathy or peripheral neuropathy. 2/52 (3.8%) patients presented with secondary hemophagocytic lymphohistiocytosis.1/52 (1.9%) patient developed pure red cell aplasia and 1/52 (1.9%) patient developed painless thyroiditis. HLA*B 58:01 allele was tested in 18/52 (34.6%) patients. 16/18 (88.9%) cases were positive. 48/52 (92.3%) patients were treated with systemic corticosteroids. 16/52 (30.8%) patients were cured, 23/52 (44.2%) patients received partial recovery, and 13/52 (25.0%) patients were died. Septic shock, gastrointestinal bleeding and multiple organ failure were the leading causes of death. Advanced age, underlying cardiovascular disease, chronic kidney disease and high dose of allopurinol, infection and internal organ involvement (including kidney, heart, lung and gastrointestinal tract) were risk factors for death. What is New and Conclusion: We explored clinical features, treatment outcomes and prognostic factors of 52 allopurinol‐induced DRESS cases in China. Ethnicity, especially Han Chinese, and positive HLA‐B*58:01 allele are the clearest risk factors so far. Advanced age, underlying cardiovascular disease, chronic kidney disease and high dose of allopurinol, infection and internal organ involvement (including kidney, heart, lung and gastrointestinal tract) were associated with poorer outcomes. Early identification and discontinuation of the causative drug are crucial to the management of DRESS. For patients with severe disease, corticosteroids are recommended as the first‐line therapy. However, further studies are needed to address diagnostic criteria of DRESS for early diagnosis, as well as to develop standardized corticosteroid treatment regimens. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. The Synergy between Pharmacological Regimens and Dermocosmetics and Its Impact on Adherence in Acne Treatment.
- Author
-
Araviiskaia, Elena, Layton, Alison Margaret, Estebaranz, Jose Luis López, Ochsendorf, Falk, and Micali, Giuseppe
- Subjects
THERAPEUTIC use of antioxidants ,CLINICAL drug trials ,ANTIBIOTICS ,COSMETICS ,ACNE ,PHYSICIAN-patient relations ,ANTI-inflammatory agents ,TREATMENT failure ,HEALTH literacy ,TREATMENT effectiveness ,DERMATOLOGIC agents ,DRUG synergism ,PATIENT compliance ,CUTANEOUS therapeutics ,DRUG eruptions - Abstract
Background. Acne is the most common inflammatory skin disease in adolescence. It is also prevalent in adults, especially females. The disease has a considerable impact on health-related quality of life. Many studies have reported the negative impact of acne on patients due to skin disfigurement, ineffective treatment, and adverse effects of the treatment. Numerous factors contribute towards nonadherence to therapy. Summary. This review discusses the various factors that are related to treatment nonadherence such as ineffective therapy, adverse effects with topical pharmacotherapy such as skin irritation and erythema as well as patient-related factors such as lack of knowledge of disease and a poor patient-physician relationship. Various methods are being adopted to increase adherence to treatments. Increased adherence to acne therapy has been associated with the use of dermocosmetics, such as moisturizers and cleansers. Encouraging the use of dermocosmetics in synergy with pharmacological regimens could support improved treatment adherence resulting in better clinical outcomes for acne patients. Conclusion. Dermocosmetics as an adjunct to pharmacological regimens has the potential to improve clinical outcomes by increasing treatment adherence in patients with acne. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Localized and Generalized Skin Adverse Drug Reactions to Nadroparin Calcium Injection in 6 Cases of Pregnant Women.
- Author
-
Chen, Ting, Lan, Liling, Sun, Wenwen, Yu, Jia, Lu, Baozhen, Chen, Lijie, Sun, Liwei, Yu, Zhendong, Wu, Bo, and Xiong, Ying
- Subjects
DRUG side effects ,PREGNANT women ,EOSINOPHILIA ,SUBCUTANEOUS injections ,CALCIUM ,SKIN ,INJECTIONS - Abstract
Background. Despite the increasing number of skin adverse drug reactions caused by nadroparin calcium have been reported, mostly, little is known regarding of their details of clinical characteristics, especially for generalized skin adverse drug reactions. We sought to evaluate localized and generalized characteristics of the skin adverse drug reaction to nadroparin calcium injection in pregnant women. Methods. A retrospective study was conducted on 6 pregnant women, who experienced localized and generalized skin adverse drug reactions during long-term nadroparin calcium injection. The patients' clinical and imaging information were retrieved from medical records. The skin prick test, patch test, and intradermal test were performed after they stopped lactation. Causality assessment of suspected adverse drug reactions was performed on these cases. Results. The average total dose of nadroparin calcium injection in the 6 cases was 64.17 ± 22.66. Localized skin adverse drug reaction, manifested as erythema at the injection point, appeared after 47.5 ± 17.4 days of subcutaneous injection of nadroparin calcium. Generalized urticaria-like lesions, progressing from the injection site on the abdomen, appeared in 5.17 ± 3.60 days after the first appearance of localized reaction, while laboratory test results revealed essential peripheral blood eosinophilia. All rashes in the 6 cases subsided in 2–5 weeks after drug withdrawal. After delivery, 5 of 6 cases received complete skin tests to evaluate drug hypersensitivity. Results presented positive in the intradermal test within 7 days. Both the skin prick test and skin patch test were negative. Localized skin reactions and generalized urticaria-like adverse drug reactions were considered as definitely and probably caused by nadroparin calcium injection, respectively. Conclusion. Subcutaneous injection of nadroparin calcium in pregnant women appears to be at risk of localized and generalized urticaria-like adverse drug reaction. It is important to follow up the pregnant woman during nadroparin calcium injection for evaluating adverse drug reactions. Timely detection of symptoms is pivotal in early diagnosis and treatment of adverse drug reactions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Clinical Study on the Relationship between the SNP rs8192675 (C/C) Site of SLC2A2 Gene and the Hypoglycemic Effect of Metformin in Type 2 Diabetes.
- Author
-
Ye, Weiwei, Wang, Yi, Chen, Feng, Zhao, Qian, Meng, Xiangying, Chen, Jianyang, Liu, Cong, and Zhou, Yong
- Subjects
TYPE 2 diabetes ,HARDY-Weinberg formula ,METFORMIN ,SINGLE nucleotide polymorphisms ,GENETIC polymorphisms - Abstract
This study investigates the correlation between the gene polymorphism of rs8192675 (C/C) locus of SLC2A2 in patients with type 2 diabetes (T2DM) and the efficacy of metformin. For this purpose, we have selected 110 T2DM patients (T2DM group) and 110 healthy people (control group) who were treated in our hospital from January 2019 to January 2020 as the research subjects. PCR-restriction fragment length polymorphism (PCR-RFLP) method detects the distribution frequency of gene polymorphism. The patients in the T2DM group were treated with metformin and followed up for 90 days to analyze the relationship between the efficacy of metformin and the SLC2A2 gene polymorphism. The genotypes of SLC2A2 rs8192675 in the control group and in the T2DM group conformed to the Hardy–Weinberg equilibrium law. Compared with the control group, the CT type and the CC type at rs8192675 in the T2DM group were significantly higher (P < 0.05). For rs8192675, there was no significant difference in TT, CT, CC FPG, 2hPBG, and HbA1c levels before treatment (P > 0.05); after metformin treatment, the reduction in FPG, 2hPBG, and HbA1c in CC patients was lower than that of TT and CT patients (P < 0.05). SLC2A2 gene polymorphism site rs8192675 CC type T2DM patients are sensitive to metformin and have a better hypoglycemic effect. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Simultaneous Oral and Umbilical Locations as a First Sign of Pemphigus Vulgaris.
- Author
-
Moussaoui, Eya, Oueslati, Yassine, Oualha, Lamia, Denguezli, Mohamed, Sriha, Badreddine, and Douki, Nabiha
- Subjects
PEMPHIGUS vulgaris ,SYMPTOMS ,MEDICAL personnel ,PROGNOSIS ,DIAGNOSIS ,PEMPHIGUS ,EPIDERMOLYSIS bullosa - Abstract
The place of pemphigus vulgaris (PV) among autoimmune bullous diseases (AIBD) is well established. It is an acquired chronic, autoimmune, vesiculobullous disease in which IgG antibodies target desmosomal proteins to produce intraepithelial mucocutaneous blistering. The diagnosis is often challenging for the clinicians. It requires a combination of three major features: clinical, histopathological, and immunological. Clinically, oral lesions are the first manifestations of the disease in 50-90% of the patients with widespread blisters affecting the oral mucosa. On the skin, lesions are characterized by flaccid blisters that rapidly progress into erosions and crust formation. Umbilical lesions as a clinical manifestation of PV are peculiar and have rarely been reported, and they are not yet completely elucidated. Umbilical region involvement in patients with pemphigus was assessed in a limited study totalling just 10 patients. This localisation may be a valuable hint easing the diagnosis at the clinical level for patients with oral mucosal blisters. Dentists must be familiar with the clinical manifestations of PV to make an early diagnosis and start an early treatment which determines the prognosis of the disease. To the best of the authors' knowledge, the coexistence of these lesions with the oral lesions as a first sign of PV in the absence of skin involvement was reported in only one case of pemphigus vegetans (PVe). In this paper, we describe an observation of a female patient that was diagnosed with PV that begun with simultaneous oral and umbilical locations which coexisted for a period of 4 months before the appearance of other cutaneous lesions. We highlight the role of dentists, by being familiar with the clinical manifestations of PV, to make an early diagnosis to start an early treatment which determines the prognosis of the disease and to follow closely the evolution of lesions to change treatment if required. We also discuss the clinical, histological, and immunological features of the disease that enabled the differential diagnosis as well as the appropriate therapeutic management. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. A case of tripterygium glycosides‐associated AGEP‐like drug reaction combined with bullous pemphigoid.
- Author
-
Sun, Ziwen, Zheng, Jianfeng, Yu, Ning, Chen, Jia, Ding, Yangfeng, and Liu, Na
- Subjects
DRUG side effects ,BULLOUS pemphigoid ,INTRAVENOUS injections ,AUTOIMMUNE diseases - Abstract
Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous drug reaction. Bullous pemphigoid (BP) is an acquired autoimmune disease that might be associated with drugs. There is currently no report of tripterygium glycosides (TG)‐induced AGEP‐like lesions combined with BP. A 66‐year‐old male with a 20‐year history of psoriasis was prescribed oral TG at 1 mg/kg, three times a day, due to aggravated psoriasis. Seven days later, erythemas, and blisters appeared. After another 3 days, there were two types of blisters: (1) numerous small tension blisters with a lot of neutrophils on the top similar to AGEP combined with BP; (2) a BP. After intravenous injection of methylprednisolone and gamma globulin, the lesions were controlled. This patient developed two types of lesions, including one similar to AGEP combined BP (AGEP‐like) and a BP. It is a rare drug reaction induced by TG. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. New safety strategies for nuclear power plants: A review.
- Author
-
Xu, Hong, Zhang, Baorui, and Liu, Yuechan
- Subjects
NUCLEAR warfare ,FUKUSHIMA Nuclear Accident, Fukushima, Japan, 2011 ,NUCLEAR energy ,NUCLEAR accidents ,NUCLEAR power plants ,EMERGENCY management ,TERRORISM - Abstract
Summary: The Extensive Damage Mitigation Guideline (EDMG), which was developed by the U.S. Nuclear Energy Institute (NEI) owing to the motivation of 911 terrorist attacks and not allowed to spread before the Fukushima nuclear accident, was publicly available after Fukushima nuclear accident and paid attention to worldwide. Many countries have adopted the U.S. EDMG methodology and developed their strategies (some are not called EDMG but have similar functions), planning to introduce it into the emergency plans of their domestic nuclear power plants (NPPs). Based on the defense‐in‐depth (DID) concept of nuclear safety, the experience of the Fukushima nuclear accident, and the state‐of‐the‐art of EDMGs research, this paper will give a comprehensive review of EDMG. To illustrate the reason for the introduction of EDMG into the traditional NPP procedures/guidelines, the review work started from the perspective of DID in nuclear safety and the reason for the Fukushima nuclear accident from the viewpoint of DID, which showed the weaknesses of DID implementation strategy ‐ underestimation of the damage during a beyond‐design‐basis external event (BDBEE). EDMG is crucial complementary for the old framework of procedures/guidelines to enhance the concept of DID. The research progress of EDMG in different countries has been reviewed and a rough comparison has been made among them according to the present state‐of‐the‐art from literature. The methodology of EDMG is summarized as follows: (a) Loss of Large Area (LOLA) ‐ the originally designed scenario for EDMG; (b) elements of EDMG ‐ the summarized contents for EDMG implementation; (c) classification of EDMG ‐ initial response EDMGs and Technical Support Center (TSC) response EDMGs; (d) implementation of EDMG‐introduction of three phases of EDMG implementation step by step. Furthermore, three typical methods to integrate EDMG into the traditional procedures/guidelines are reviewed. Finally, this paper gives some concluding remarks for EDMG‐related critical issues and recommended future work, which may be challenges for the development and application of EDMG and useful for the related researchers. Novelty Statement: The studies of the extensive damage mitigation guideline (EDMG), its methodology, and the progress in different countries have been reviewed.Three typical methods to integrate EDMG into the traditional procedures/guidelines are summarized and reviewed.Concluding remarks for EDMG‐related critical issues and recommended future work are summarized. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Improving the stability of perovskite by covering graphene on FAPbI3 surface.
- Author
-
Sun, Xueli, Li, Xiaoyan, Zeng, Yanli, and Meng, Lingpeng
- Subjects
GRAPHENE ,PEROVSKITE ,SOLAR cells ,HETEROJUNCTIONS ,ELECTRONIC structure ,MECHANICAL properties of condensed matter ,DRYING agents - Abstract
Summary: Organic‐inorganic hybrid perovskites have caused great interest owing to their ever‐increasing power conversion efficiencies and extensive application prospects. However, the instability under ambient environment hinders their large‐scale commercialization. In this paper, the geometries, electronic structures, photoelectric properties, and stabilities of FAPbI3 (001) surfaces, graphene sheet, and graphene/FAPbI3 heterojunctions were explored using first‐principles calculations. Our calculated results show that a stable heterojunction can be constructed from graphene sheet and FAPbI3 (001) surface by van der Waals interaction. The construction of heterojunction has little influence on the effective masses of carriers, band structure, and optical absorbance of the perovskites. The graphene sheet of heterojunction can block the infiltration of O2 and H2O molecules and protect the perovskite from the degradation in light and humid air. Therefore, assembling a heterojunction from graphene sheet and FAPbI3 surface is an effective strategy for improving the stability and photoelectric properties of perovskite materials. Our study provides an atomic‐level insight into the fundamental properties of the graphene/FAPbI3 heterojunctions and a guideline for designing more stable perovskite solar cells. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. Cutaneous Manifestations of "Lupus": Systemic Lupus Erythematosus and Beyond.
- Author
-
Cooper, Elizabeth E., Pisano, Catherine E., and Shapiro, Samantha C.
- Subjects
LUPUS erythematosus ,CUTANEOUS manifestations of general diseases ,SYSTEMIC lupus erythematosus - Abstract
Lupus, Latin for "wolf," is a term used to describe many dermatologic conditions, some of which are related to underlying systemic lupus erythematosus, while others are distinct disease processes. Cutaneous lupus erythematosus includes a wide array of visible skin manifestations and can progress to systemic lupus erythematosus in some cases. Cutaneous lupus can be subdivided into three main categories: acute cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, and chronic cutaneous lupus erythematosus. Physical exam, laboratory studies, and histopathology enable differentiation of cutaneous lupus subtypes. This differentiation is paramount as the subtype of cutaneous lupus informs upon treatment, disease monitoring, and prognostication. This review outlines the different cutaneous manifestations of lupus erythematosus and provides an update on both topical and systemic treatment options for these patients. Other conditions that utilize the term "lupus" but are not cutaneous lupus erythematosus are also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Enhanced Hypercoagulability in Sickle Cell Anaemia Patients with Chronic Leg Ulcers.
- Author
-
Sackey, David, Dei-Adomakoh, Yvonne, and Olayemi, Edeghonghon
- Subjects
SICKLE cell anemia ,LEG ulcers ,THROMBOEMBOLISM ,BLOOD platelet activation ,PLATELET count - Abstract
Sickle Cell Anaemia (SCA) is associated with a hypercoagulable state resulting in a predisposition to venous thromboembolism. With improvements in the quality of care, more patients with SCA survive into adulthood with an associated increase in the frequency of end-organ damage and chronic complications such as chronic leg ulcers (CLUs). These ulcers rarely occur in the first decade of life and are recurrent, painful, and slow-to-heal. This study tested the hypothesis that coagulation is enhanced in SCA patients with CLU. 145 participants (50 SCA with CLU, 50 SCA without CLU, and 45 with haemoglobin AA) were assessed to determine their coagulation profile using selected tests of coagulation. The SCA with the CLU group had the lowest mean haemoglobin (Hb) concentration. SCA patients with and without CLUs had elevated mean platelet counts, shorter mean aPTT, and marginally prolonged mean PT compared to HbAA patients. SCA with CLUs patients had a significantly shortened aPTT than those without CLUs (p = 0.035) and HbAA (p = 0.009). There were significant differences in the mean PT between SCA with CLUs patients and HbAA (p = 0.017); SCA without CLU and HbAA (p = 0.014). SCA with and without CLUs patients had higher mean D-dimer levels compared to HbAA. There was a negative correlation between Hb concentration and duration of CLU (r = -0.331, p = 0.021). In conclusion, our study demonstrates a heightened hypercoagulability in SCA patients with CLUs. We did not test for platelet activation, and it is not clear what role, if any, the enhanced hypercoagulability plays in the pathogenesis of CLUs in SCA. It will be useful to ascertain if antiplatelet agents or/and anticoagulants quicken the healing of CLUs in SCA patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Alendronate induced subacute cutaneous lupus erythematosus successfully treated with intravenous immunoglobulin.
- Author
-
Uzuncakmak, Tugba Kevser, Bayazit, Samet, Askin, Ozge, Engin, Burhan, Ugurlu, Serdal, Sar, Mehmet, and Serdaroglu, Server
- Subjects
LUPUS erythematosus ,ALENDRONATE ,PROTON pump inhibitors ,TERBINAFINE ,MEDICAL protocols - Abstract
The subacute cutaneous lupus erythematosus (SCLE) is a distinct subtype of lupus erythematosus (LE) representing specific clinical and serological features. Almost 20%‐30% of the cases with SCLE are predicted to associated with medications. Thiazide diuretics, terbinafine, antiepileptic, and proton pump inhibitors are the best‐known drugs to induce drug‐related SCLE. Herein we want to present a 65‐year‐old female with alendronate induced SCLE, resistant to classical therapies, and respond well to intravenous immunoglobulin (IVIG), suggesting that IVIG could be an alternative treatment in patients resistant to classical treatment protocols. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
23. COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum.
- Author
-
Almutairi, Nawaf and Schwartz, Robert A.
- Subjects
COVID-19 ,SARS-CoV-2 ,DRUG side effects ,MEDICAL care - Abstract
The novel coronavirus SARS‐CoV‐2 has caused Coronavirus Disease 2019, widely known as COVID‐19, now a pandemic with extraordinary infectivity, mortality, and fomite adhesiveness. We delineate cutaneous manifestations of COVID‐19, some of which may represent adverse cutaneous drug reactions, and skin changes associated with COVID‐19 lifestyle alterations in patients and health care workers. We review COVID‐19 from both a dermatologic and public health perspective. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
24. Erythrodermic psoriasis in a dialyzed patient successfully treated with Secukinumab.
- Author
-
Pizzatti, Laura, Mugheddu, Cristina, Sanna, Silvia, Atzori, Laura, and Rongioletti, Franco
- Subjects
PSORIASIS ,PATIENT safety ,KIDNEY failure ,PROBLEM patients ,DRUG side effects - Abstract
Erythrodermic psoriasis is a severe, life‐threatening condition with additional complications, when occurring in hemodialyzed patients, as the majority of treatments are contraindicated. A 44‐years‐old man, of Philippine origins, with a 15‐years‐history of psoriasis treated with cyclosporine developed progressive hypertension and renal insufficiency. Despite drug dismission, renal function worsen to end‐stage, and hemodialysis was necessary three times a week. Phototherapy was not able to control the skin condition, progressing to erythroderma, and after nephrology consultation, the patient consent to the off‐label secukinumab treatment, at the standard regimen (300 mg subcutaneously once weekly at weeks 0‐4 followed by 300 mg every 4 weeks). Seven days after the first injection, a rapid improvement was noted, with the psoriasis area severity index (PASI) score passing from 31.5 to 17.6. At the 52‐week‐follow‐up visit, the patient was completely clarified, without any side effects. The case supports secukinumab effectiveness and safety in difficult patients, including erythrodermic psoriasis with end‐stage renal failure, as drug plasma levels seem not to be affected by hemodialysis. Results are rapidly achieved, and long term maintained, with the additional advantage of a very comfortable monthly administration. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
25. Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis.
- Author
-
Napolitano, Maddalena, Gallo, Lucia, Megna, Matteo, Fabbrocini, Gabriella, Nocerino, Mariateresa, Abategiovanni, Luisa, and Patruno, Cataldo
- Subjects
PSORIATIC arthritis ,ALLERGIES ,ANAPHYLAXIS ,MONOCLONAL antibodies - Abstract
The pathogenic mechanism of hypersensitivity reactions (HSRs) to monoclonal antibodies is not fully understood. HSRs can occur after the first exposure or multiple exposures and include acute infusion reactions induced by cytokine release, besides Type I, Type III, and Type IV reactions.). We reported a case of anaphylactic reaction to certolizumab pegol in a patient affected by psoriatic arthritis and a possible management of this condition. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
26. Neutrophilic Dermatoses and Their Implication in Pathophysiology of Asthma and Other Respiratory Comorbidities: A Narrative Review.
- Author
-
Salem, Iman, Kimak, Mark, Conic, Rosalynn, Bragazzi, Nicola L., Watad, Abdulla, Adawi, Mohammad, Bridgewood, Charlie, Pacifico, Alessia, Santus, Pierachille, Rizzi, Maurizio, Petrou, Stephen, Colombo, Delia, Fiore, Marco, Pigatto, Paolo D. M., and Damiani, Giovanni
- Subjects
ASTHMA treatment ,TREATMENT of respiratory diseases ,ASTHMA ,INTERLEUKIN-1 ,NEUTROPHILS ,RESPIRATORY diseases ,TUMOR necrosis factors ,COMORBIDITY ,SWEET'S syndrome ,DISEASE complications - Abstract
Neutrophilic dermatoses (ND) are a polymorphous group of noncontagious dermatological disorders that share the common histological feature of a sterile cutaneous infiltration of mature neutrophils. Clinical manifestations can vary from nodules, pustules, and bulla to erosions and ulcerations. The etiopathogenesis of neutrophilic dermatoses has continuously evolved. Accumulating genetic, clinical, and histological evidence point to NDs being classified in the spectrum of autoinflammatory conditions. However, unlike the monogenic autoinflammatory syndromes where a clear multiple change in the inflammasome structure/function is demonstrated, NDs display several proinflammatory abnormalities, mainly driven by IL-1, IL-17, and tumor necrosis factor-alpha (TNF-a). Additionally, because of the frequent association with extracutaneous manifestations where neutrophils seem to play a crucial role, it was plausible also to consider NDs as a cutaneous presentation of a systemic neutrophilic condition. Neutrophilic dermatoses are more frequently recognized in association with respiratory disorders than by chance alone. The combination of the two, particularly in the context of their overlapping immune responses mediated primarily by neutrophils, raises the likelihood of a common neutrophilic systemic disease or an aberrant innate immunity disorder. Associated respiratory conditions can serve as a trigger or may develop or be exacerbated secondary to the uncontrolled skin disorder. Physicians should be aware of the possible pulmonary comorbidities and apply this knowledge in the three steps of patients' management, work-up, diagnosis, and treatment. In this review, we attempt to unravel the pathophysiological mechanisms of this association and also present some evidence for the role of targeted therapy in the treatment of both conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
27. Neutrophilic Dermatosis of the Dorsal Hands: Report of a Case and Review of the Literature.
- Author
-
Mobini, Narciss, Sadrolashrafi, Kaviyon, and Michaels, Susun
- Subjects
SWEET'S syndrome ,HEMATOLOGIC malignancies ,WOUND care ,DEBRIDEMENT ,EDEMA ,LITERATURE reviews - Abstract
Neutrophilic dermatosis of the dorsal hands is an underrecognized entity, which is a distributional variant of Sweet's syndrome. It is often clinically misdiagnosed as an infectious process in overwhelming majority of the cases and the treatment is therefore delayed. Also, its association with underlying systemic and neoplastic disorders makes the need for an accurate diagnosis more crucial. We present a 45-year-old Caucasian woman who was initially diagnosed as having a hand infection with unsuccessful courses of antibiotic therapy. A later biopsy revealed a diffuse dermal infiltrate of neutrophils with leukocytoclasis, vasculopathic changes, and marked papillary dermal edema. Patient responded rapidly to oral prednisone treatment. By sharing a new case and comprehensive review of available published literature, we intend to raise awareness of this underreported entity and emphasize the role of timely biopsy of the lesions that will not only lead to an accurate diagnosis, but also avoid unnecessary antibiotic treatments, potentially aggressive management strategies such as surgical debridement or amputation, and referrals to wound care centers. More importantly, it will prompt a search to exclude any possible association, particularly hematopoietic malignancies. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
28. Acute generalized exanthematous pustulosis caused by propafenone: An emerging skin adverse reaction.
- Author
-
Conforti, Claudio, di Meo, Nicola, Giuffrida, Roberta, Retrosi, Chiara, Vezzoni, Roberta, Romita, Paolo, Bussani, Rossana, and Zalaudek, Iris
- Subjects
FOLLICULITIS ,DRUG side effects ,SKIN - Published
- 2020
- Full Text
- View/download PDF
29. Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service.
- Author
-
Capelle, H., Tummino, C., Greillier, L., Gouitaa, M., Birnbaum, J., Ausias, N., Barlesi, F., and Montana, M.
- Subjects
DRUG allergy ,CANCER chemotherapy ,CHEST tumors ,PLATINUM compounds ,SKIN tests ,RETROSPECTIVE studies ,DIAGNOSIS - Abstract
Summary: What is known and objective: With the increasing use of cancer chemotherapy agents, hypersensitivity reactions are commonly encountered. The allergic clinical symptoms are variable and unpredictable. The aim of this study was to identify the characteristics of hypersensitivity reactions and to assess the value of skin tests for platinum salts and pemetrexed in the treatment of patients with non‐small cell lung cancers or malignant pleural mesothelioma. Methods: A single‐centre retrospective study was performed for 2 years. Patients treated with the drugs of interest for an advanced or metastatic non‐small cell lung cancers or malignant pleural mesothelioma and who experienced hypersensitivity reactions symptoms were eligible for this study. Clinical symptoms of hypersensitivity reactions, population characteristics and administered chemotherapy regimens were identified. Results: The hypersensitivity reactions frequency was rare (1.2%) and concerned 17 patients in our study. Typical clinical features of immediate hypersensitivity reactions associated with treatment were observed for nine patients (anaphylactic reactions for three cases, angioedema and hypotension associated with asthenia and heat in one case, respectively, and other cutaneous symptoms in the remaining four cases). Skin tests were positive in three patients, but only for platinum salts. The outcome after reintroduction of a negatively tested platinum salt allowed us to calculate a negative predictive value for platinum salt skin tests of 100%. For pemetrexed, skin tests were negative for all patients. What is new and conclusion: Skin tests could be used to diagnose hypersensitivity reactions with platinum salts or to evaluate the possibility of cross‐reactions between two platinum salts. A negative skin test may predict with reasonable reliability the absence of future hypersensitivity reactions in case of reintroduction of drug infusion. Because the IgE‐mediated mechanism has never been demonstrated for pemetrexed, skin tests are not valid and have no diagnostic value for this molecule. Because hypersensitivity reactions are potentially fatal adverse events, we recommend that patients who experience a hypersensitivity reactions onset should be monitored closely and clinicians must be aware of hypersensitivity reaction signs. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
30. Effects of Transplanted Heparin-Poloxamer Hydrogel Combining Dental Pulp Stem Cells and bFGF on Spinal Cord Injury Repair.
- Author
-
Luo, Lihua, Albashari, Abdullkhaleg Ali, Wang, Xiaoyan, Jin, Ling, Zhang, Yanni, Zheng, Lina, Xia, Jianjian, Xu, Helin, Zhao, Yingzheng, Xiao, Jian, He, Yan, and Ye, Qingsong
- Subjects
SPINAL cord injuries ,THERAPEUTICS ,DENTAL pulp ,TISSUE engineering ,HEPARIN ,HYDROGELS - Abstract
Spinal cord injury (SCI) is one of serious traumatic diseases of the central nervous system and has no effective treatment because of its complicated pathophysiology. Tissue engineering strategy which contains scaffolds, cells, and growth factors can provide a promising treatment for SCI. Hydrogel that has 3D network structure and biomimetic microenvironment can support cellular growth and embed biological macromolecules for sustaining release. Dental pulp stem cells (DPSCs), derived from cranial neural crest, possess mesenchymal stem cell (MSC) characteristics and have an ability to provide neuroprotective and neurotrophic properties for SCI treatment. Basic fibroblast growth factor (bFGF) is able to promote cell survival and proliferation and also has beneficial effect on neural regeneration and functional recovery after SCI. Herein, a thermosensitive heparin-poloxamer (HP) hydrogel containing DPSCs and bFGF was prepared, and the effects of HP-bFGF-DPSCs on neuron restoration after SCI were evaluated by functional recovery tests, western blotting, magnetic resonance imaging (MRI), histology evaluation, and immunohistochemistry. The results suggested that transplanted HP hydrogel containing DPSCs and bFGF had a significant impact on spinal cord repair and regeneration and may provide a promising strategy for neuron repair, functional recovery, and tissue regeneration after SCI. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
31. An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.
- Author
-
Chen, Chun-Bing, Abe, Riichiro, Pan, Ren-You, Wang, Chuang-Wei, Hung, Shuen-Iu, Tsai, Yi-Giien, and Chung, Wen-Hung
- Subjects
DRUG allergy ,DRUG side effects ,SKIN diseases ,HLA histocompatibility antigens ,THERAPEUTICS ,ALLERGY treatment ,ANTIGENS ,BIOMARKERS ,CELL receptors ,DRUG eruptions ,ETHNIC groups ,GENETIC polymorphisms ,PHARMACOGENOMICS ,T cells ,URTICARIA ,HLA-B27 antigen ,RELATIVE medical risk ,GENOTYPES - Abstract
Drug hypersensitivity may manifest ranging from milder skin reactions (e.g., maculopapular exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS), or Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Current pharmacogenomic studies have made important strides in the prevention of some drug hypersensitivity through the identification of relevant genetic variants, particularly for genes encoding drug-metabolizing enzymes and human leukocyte antigens (HLAs). The associations identified by these studies are usually drug, phenotype, and ethnic specific. The drug presentation models that explain how small drug antigens might interact with HLA and T cell receptor (TCR) molecules in drug hypersensitivity include the hapten theory, the p-i concept, the altered peptide repertoire model, and the altered TCR repertoire model. The broad spectrum of clinical manifestations of drug hypersensitivity involving different drugs, as well as the various pathomechanisms involved, makes the diagnosis and management of it more challenging. This review highlights recent advances in our understanding of the predisposing factors, immune mechanisms, pathogenesis, diagnostic tools, and therapeutic approaches for drug hypersensitivity. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
32. CMR2009: 7.01: Hyperpolarized carbon-13 metabolic imaging, technique and applications in cancer and ischemia, early results, part 1 and 2.
- Author
-
Åkeson, P., Magnusson, P., Vejby Søgaard, L., Butt, S., Hauge Lauritzen, M., and Golman, K.
- Published
- 2009
- Full Text
- View/download PDF
33. Revisiting genotype-phenotype overlap in neurogenetics: Triplet-repeat expansions mimicking spastic paraplegias.
- Author
-
Bettencourt, Conceição, Quintáns, Beatriz, Ros, Raquel, Ampuero, Israel, Yáñez, Zuleima, Pascual, Samuel Ignacio, de Yébenes, Justo García, and Sobrido, María-Jesús
- Abstract
Hereditary spastic paraplegias (HSPs) constitute a heterogeneous group of neurological disorders, characterized primarily by progressive spasticity and weakness of the lower limbs. HSPs are caused by mutations in multiple genes (at least 48 loci and 28 causative genes). The clinical spectrum of HSPs is wide and important differences have been reported between patients with distinct mutations in the same gene, or even between different family members bearing the same mutation. Many patients with HSP present clinical deficits related to the involvement of neuronal systems other than corticospinal tracts, namely, peripheral nerves, sensory, or cerebellar pathways. These cases may be difficult to differentiate from other neurological diseases (e.g., hereditary ataxias), also genetically and clinically heterogeneous. As an illustration of how overlapping this genotype-phenotype relationship is, and the difficulties that it brings upon the development of neurogenetic algorithms and databases, we review the main clinical and genetic features of HSPs, and summarize reports on cases of triplet-repeat spinocerebellar ataxias that can mimic HSP phenotypes. This complex scenario makes the necessity of high-quality, curated mutation databases even more urgent, in order to develop adequate diagnostic guidelines, correct interpretation of genetic testing, and appropriate genetic counseling. Hum Mutat 33:1315-1323, 2012. © 2012 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
34. Management of leg ulcers in patients with chronic venous insufficiency: the experience of a Dermatology Clinic in Bucharest, Romania.
- Author
-
Salavastru, C. M., Nedelcu, L. E., and Ţiplica, G-S.
- Subjects
VENOUS insufficiency ,LEG ulcers ,BACTERIOLOGY ,ULCERS ,SCLEROTHERAPY ,ENTEROBACTER ,STAPHYLOCOCCUS aureus - Abstract
Venous ulcers are the most severe skin manifestation of chronic venous insufficiency. Treatment is complex and it is performed according to the stage of the disease. It includes changes of lifestyle, compressive therapy, phlebotropic medication, topical therapy of the ulcer, antibiotic therapy (topical and systemic), sclerotherapy, and surgical treatment. Patients with venous leg ulcers that attend the Second Dermatology Clinic of Colentina Clinical Hospital, are treated both as inpatients and as outpatients. They benefit from topical treatment and bandaging performed by specialized medical personnel in separate treatment room with strictly monitored conditions of asepsis and antisepsis. A follow-up study of these patients was made from January 1, 2009 to December 31, 2011. The average age of patients was 65.9 years (± 14.2), most of them being in the eight decade of life (31.9%). In almost half of the cases (44.2%), the patients spent more than 1 week in the hospital. Bacteriological investigations from the ulcers were performed in 55.1% of patients and the most frequent infectious agents were found to be Staphylococcus aureus (26.3%) and Enterobacter spp. (17.2%). Treatment of leg ulcer patients proves to be a long and complex one, a systematic and organized approach being needed in order to obtain healing of the wound. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
35. The presence of iodinated contrast agents amplifies DNA radiation damage in computed tomography.
- Author
-
Pathe, Caroline, Eble, Katharina, Schmitz-Beuting, Daniel, Keil, Boris, Kaestner, Bjoern, Voelker, Maximilian, Kleb, Beate, Klose, Klaus J., and Heverhagen, Johannes T.
- Abstract
The purpose of this study was to determine the influence of iodinated contrast agents on the formation of DNA double-strand breaks in vitro in lymphocytes and to verify these results in patients undergoing diagnostic computed tomography examinations. Blood samples were irradiated in vitro in the presence of iodinated X-ray contrast agent. Controls were irradiated without contrast agent. Fourteen patients were investigated using contrast-enhanced computed tomography (CT), and 14 other patients with unenhanced CT. Blood samples were taken prior to and 5 min and 1, 2 and 24 h after the CT examination. In these blood samples the average number of γH2Ax-foci per lymphocyte was enumerated by fluorescence microscopy. Statistical differences between foci numbers developed in the presence and absence of contrast agent were tested using an independent sample t-test. In vitro foci numbers after irradiation were significantly higher when contrast agent was present during irradiation. In vivo, γH2Ax-foci levels were 58% higher in patients undergoing contrast-enhanced CT compared with those undergoing unenhanced CT. In the presence of iodinated contrast agents DNA, damage is increased and the radiation dose is not the only factor affecting the amount of DNA damage. Individual patient characteristics and biological dosimetry applications, e.g. the analysis of γH2Ax-foci, have to be considered. Copyright © 2011 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
36. Acne Scars: Pathogenesis, Classification and Treatment.
- Author
-
Fabbrocini, Gabriella, Annunziata, M. C., D'Arco, V., De Vita, V., Lodi, G., Mauriello, M. C., Pastore, F., and Monfrecola, G.
- Abstract
Acne has a prevalence of over 90% among adolescents and persists into adulthood in approximately 12%-14% of cases with psychological and social implications. Possible outcomes of the inflammatory acne lesions are acne scars which, although they can be treated in a number of ways, may have a negative psychological impact on social life and relationships. The main types of acne scars are atrophic and hypertrophic scars. The pathogenesis of acne scarring is still not fully understood, but several hypotheses have been proposed. There are numerous treatments: chemical peels, dermabrasion/microdermabrasion, laser treatment, punch techniques, dermal grafting, needling and combined therapies for atrophic scars: silicone gels, intralesional steroid therapy, cryotherapy, and surgery for hypertrophic and keloidal lesions. This paper summarizes acne scar pathogenesis, classification and treatment options. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
37. Expanded GAA repeats and clinical variation in Friedreich's ataxia.
- Author
-
Mateo, I., Llorca, J., Volpini, V., Corral, J., Berciano, J., and Combarros, 0.
- Subjects
FRIEDREICH'S ataxia ,SCOLIOSIS ,NEUROPATHY ,SPHINCTERS ,MUSCULAR atrophy ,ARTICULATION disorders - Abstract
Mateo I, Llorca J, Volpini V, Corral J, Berciano J, Combarros O. Expanded GAA repeats and clinical variation in Friedreich's ataxia. Acta Neurol Scand 2003 DOI: 10.1046/j.1600-0404.2003.00190.x © Blackwell Munksgaard 2003. One of the main features of Friedreich's ataxia (FA) is phenotypic variability that can now be explained by the molecular mechanism (GAA expansion) underlying the disease. We have analyzed genotype-phenotype correlations in a group of 40 patients homozygous for the GAA expansion. The smaller GAA expansion (GAA1 allele) size correlated with age at onset and progression disease rate, but we found no correlation between the larger GAA expansion (GAA2 allele) size and these clinical parameters. The frequency of pes cavus, scoliosis, axonal sensory neuropathy and areflexia increased with the size of GAA1, whereas some signs such as sphincter disturbances, cerebellar atrophy on MRI, amyotrophy, dysarthria and decreased vibration sense were associated with increased duration of the disease. GAA1 size is the main determinant of FA phenotype and GAA2 size is a poor predictor of clinical variation. Some clinical features are independent of GAA1 and GAA2 sizes and are determined by the duration of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
38. Treatment of prurigo nodularis with pregabalin.
- Author
-
Mazza, M., Guerriero, G., Marano, G., Janiri, L., Bria, P., and Mazza, S.
- Subjects
HEALTH outcome assessment ,SKIN diseases ,VISUAL analog scale ,TREATMENT effectiveness ,PREGABALIN ,DESCRIPTIVE statistics - Abstract
What is known and objective: Prurigo nodularis (PN) is a chronic skin condition that is difficult to treat. Pregabalin is one of the possible treatments for PN but its safety and efficacy are not well defined. We aimed to assess the efficacy of pregabalin in patients with PN. Methods: Thirty patients (10 men, 20 women; mean age 51.6 ± 9.39 years) were treated with pregabalin (75 mg/day) for 3 months. Efficacy was classified as (i) successful (disappearance of the pruritus and reduction of nodules); (ii) slight improvement/reduction of the nodules, that is, number and/or flattening, no disappearance of itching; or (iii) unsuccessful. Results: Twenty-three patients (76%) responded successfully after 3 months of treatment. There was a statistically significant difference between visual analogue scale scores before and after 1 month treatment period (8·15 ± 2·04 and 1·5 ± 1·12, respectively; P < 0·0001). Pregabalin was generally well tolerated with only six (20%) patients reporting side effects. No patient showed any renal insufficiency. What is new and conclusion: In our study, pregabalin was effective for the treatment of PN. However, given the open and non-controlled study design used, a properly powered randomized controlled validation study is called for. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
39. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
- Author
-
Kumar, Sumir, Bhale, Gauri, and Brar, Balvinder K.
- Subjects
DRUG side effects ,TOXIC epidermal necrolysis ,DRUGS ,STEVENS-Johnson Syndrome ,ORAL medication ,BLOOD cell count - Abstract
In our scenario, patient was diagnosed with Symmetrical drug related intertriginous and flexural exanthema due to fluconazole, based on the clinical features and drug history. Baboon syndrome resulting from systemic drugs: Is there strife between SDRIFE and allergic contact dermatitis syndrome?. [Extracted from the article]
- Published
- 2019
- Full Text
- View/download PDF
40. Infliximab-induced acne and acute localized exanthematous pustulosis: Case report.
- Author
-
Senilă, Simona, Seicean, Andrada, Fechete, Oana, Grad, Alecsandra, and Ungureanu, Loredana
- Subjects
INFLIXIMAB ,SKIN diseases - Published
- 2017
- Full Text
- View/download PDF
41. Angiotensin‐converting‐enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review.
- Author
-
Palleria, Caterina, Iannone, Luigi F., Manti, Antonia, Russo, Emilio, De Sarro, Giovambattista, Bennardo, Luigi, Dastoli, Stefano, Silvestri, Martina, and Nisticò, Steven P.
- Subjects
ANGIOTENSIN converting enzyme ,ANGIOTENSIN II ,ACE inhibitors ,ANGIOTENSIN receptors ,AUTOIMMUNE diseases ,PEMPHIGUS - Abstract
Pemphigus is a group of autoimmune diseases characterized by the formation of erosions and/or flaccid bullae of the skin and/or mucosae. The definition "drug‐induced pemphigus" has been coined to indicate cases of pemphigus with clinical, histological and immunopathologic features similar to those of the idiopathic disease but induced by systemic ingestion or local use of some drugs. The present authors analyzed a case series of three case reports with clinical and pharmacological features compatible with the diagnosis of angiotensin converting enzyme inhibitors or angiotensin II receptor blocker drug‐induced pemphigus. The patients were visited by the dermatological Unit of Magna Graecia University in Catanzaro. All suspected drug induced pemphigus were treated by suspending the suspected drug and by starting a treatment with systemic corticosteroid drugs, leading to a remission of the clinical manifestations in some months. When a drug induced bullous disease is probable, it is necessary to interrupt the suspected substance and to start a high dose treatment with corticosteroid drugs to resolve the clinical case in a short period of time. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
42. CMR2009: 7.02: Hyperpolarized 1,4-13C2 fumarate - a new diagnostic agent for oncology.
- Author
-
Rose Jensen, P., Karlsson, M., in 't Zandt, R., Gisselsson, A., Hansson, G., and Lerche, M. H.
- Published
- 2009
- Full Text
- View/download PDF
43. CMR2009: 6.03: Immediate hypersensitivity reactions to iodinated or gadolinated contrast media: ongoing results of the CIRTACI study, a french prospective multicenter trial.
- Author
-
Clément, O., Laroche, D., Mouton, C., and Dewachter, P.
- Published
- 2009
- Full Text
- View/download PDF
44. CMR 2005: 12.01: High-resolution x-ray microtomography of spleen in living mice.
- Author
-
Almajdub, M., Magnier, L., Chereul, E., and Janier, M.
- Published
- 2006
- Full Text
- View/download PDF
45. CMR 2005: 11.05: Immunological mechanisms of delayed-type hypersensitivity reactions to iodinated contrast media.
- Author
-
Lerch, M., Keller, M., Britschgi, M., Kanny, G., Tâche, V., Schmid, D., Gerber, B.O., Bircher, A.J., Christiansen, C., and Pichler, W.J.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.